Lantern Pharma Inc.

NASDAQ: LTRN · Real-Time Price · USD
4.61
0.04 (0.88%)
At close: Aug 15, 2025, 3:59 PM
4.66
1.08%
After-hours: Aug 15, 2025, 04:32 PM EDT

Lantern Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-20.78M -15.96M -14.26M -12.36M
Depreciation & Amortization
17.28K 14.62K 10.08K 6.76K
Stock-Based Compensation
732.89K 1.07M 1.19M 961.54K
Other Working Capital
2.23M 933.46K -1.03M -950.47K
Other Non-Cash Items
-10.32K -5.17K 906.49K 90.66K
Deferred Income Tax
n/a n/a n/a 112.56K
Change in Working Capital
2.23M 538.02K -611.86K 599.96K
Operating Cash Flow
-17.81M -14.35M -12.77M -10.59M
Capital Expenditures
-12.6K -18.73K -27.84K -15.5K
Cash Acquisitions
n/a n/a -179.27M 19.53B
Purchase of Investments
-17.28M -8.2M -3.91M -19.58M
Sales Maturities Of Investments
20.66M 7.28M 4.12M 64.09K
Other Investing Acitivies
n/a n/a 179.27M -19.53B
Investing Cash Flow
3.37M -930.21K 179.27K -19.53M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -500K -2.48M -939.67K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a -4.64M
Financial Cash Flow
66.71K -500K -2.18M 63.42M
Net Cash Flow
-14.43M -15.81M -13.78M 33.3M
Free Cash Flow
-17.83M -14.37M -12.8M -10.61M